Despite another beat-and-raise quarter for Palantir, the stock’s after-hours reaction was somewhat muted. Check out PLTR's ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

We don’t need to give up on surveys altogether. We just have to enter a new era in which people are no longer reduced to ...